{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:48:35Z","timestamp":1794037715960,"version":"4.8.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"7971","license":[{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2023,7,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Splice-switching antisense oligonucleotides (ASOs) could be used to treat a subset of individuals with genetic diseases\n                    <jats:sup>1<\/jats:sup>\n                    , but the systematic identification of such individuals remains a challenge. Here we performed whole-genome sequencing analyses to characterize genetic variation in 235 individuals (from 209 families) with ataxia-telangiectasia, a severely debilitating and life-threatening recessive genetic disorder\n                    <jats:sup>2,3<\/jats:sup>\n                    , yielding a complete molecular diagnosis in almost all individuals. We developed a predictive taxonomy to assess the amenability of each individual to splice-switching ASO intervention; 9% and 6% of the individuals had variants that were \u2018probably\u2019 or \u2018possibly\u2019 amenable to ASO splice modulation, respectively. Most amenable variants were in deep intronic regions that are inaccessible to exon-targeted sequencing. We developed ASOs that successfully rescued mis-splicing and ATM cellular signalling in patient fibroblasts for two recurrent variants. In a pilot clinical study, one of these ASOs was used to treat a child who had been diagnosed with ataxia-telangiectasia soon after birth, and showed good tolerability without serious adverse events for three years. Our study provides a framework for the prospective identification of individuals with genetic diseases who might benefit from a therapeutic approach involving splice-switching ASOs.\n                  <\/jats:p>","DOI":"10.1038\/s41586-023-06277-0","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T12:01:59Z","timestamp":1689163319000},"page":"828-836","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":184,"title":["A framework for individualized splice-switching oligonucleotide therapy"],"prefix":"10.1038","volume":"619","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0564-3294","authenticated-orcid":false,"given":"Jinkuk","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijae","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio M.","family":"de Gusmao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2337-5756","authenticated-orcid":false,"given":"Boxun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1645-3552","authenticated-orcid":false,"given":"Diana H.","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata L.","family":"DiDonato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh A.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2110-6878","authenticated-orcid":false,"given":"Tojo","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunguang April","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8633-0032","authenticated-orcid":false,"given":"Aubrie","family":"Soucy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Kuniholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Karlin","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Riccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle A.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle Moufawad","family":"El Achkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7536-9622","authenticated-orcid":false,"given":"Zane","family":"Dash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cornelissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Donado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamli N. W.","family":"Faour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn W.","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Suslovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Lentucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9378-960X","authenticated-orcid":false,"given":"Peter J.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6574-9261","authenticated-orcid":false,"given":"Eunjung Alice","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony A.","family":"Philippakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5447-6630","authenticated-orcid":false,"given":"Brad","family":"Margus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles B.","family":"Berde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2988-7701","authenticated-orcid":false,"given":"Timothy W.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,12]]},"reference":[{"key":"6277_CR1","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1056\/NEJMoa1813279","volume":"381","author":"J Kim","year":"2019","unstructured":"Kim, J. et al. Patient-customized oligonucleotide therapy for a rare genetic disease. N. Engl. J. Med. 381, 1644\u20131652 (2019).","journal-title":"N. Engl. J. Med."},{"key":"6277_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13023-016-0543-7","volume":"11","author":"C Rothblum-Oviatt","year":"2016","unstructured":"Rothblum-Oviatt, C. et al. Ataxia telangiectasia: a review. Orphanet J. Rare Dis. 11, 159 (2016).","journal-title":"Orphanet J. Rare Dis."},{"key":"6277_CR3","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1212\/WNL.0b013e3181af33bd","volume":"73","author":"MMM Verhagen","year":"2009","unstructured":"Verhagen, M. M. M. et al. Clinical spectrum of ataxia-telangiectasia in adulthood. Neurology 73, 430\u2013437 (2009).","journal-title":"Neurology"},{"key":"6277_CR4","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13023-018-0936-x","volume":"13","author":"P Kaufmann","year":"2018","unstructured":"Kaufmann, P., Pariser, A. R. & Austin, C. From scientific discovery to treatments for rare diseases\u2014the view from the National Center for Advancing Translational Sciences\u2013Office of Rare Diseases Research. Orphanet J. Rare Dis. 13, 196 (2018).","journal-title":"Orphanet J. Rare Dis."},{"key":"6277_CR5","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/ajmg.a.61124","volume":"179","author":"CR Ferreira","year":"2019","unstructured":"Ferreira, C. R. The burden of rare diseases. Am. J. Med. Genet. A 179, 885\u2013892 (2019).","journal-title":"Am. J. Med. Genet. A"},{"key":"6277_CR6","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1056\/NEJMe1911295","volume":"381","author":"J Woodcock","year":"2019","unstructured":"Woodcock, J. & Marks, P. Drug regulation in the era of individualized therapies. N. Engl. J. Med. 381, 1678\u20131680 (2019).","journal-title":"N. Engl. J. Med."},{"key":"6277_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrc1011","volume":"3","author":"Y Shiloh","year":"2003","unstructured":"Shiloh, Y. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer 3, 155\u2013168 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"6277_CR8","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/ana.25394","volume":"85","author":"K Schon","year":"2019","unstructured":"Schon, K. et al. Genotype, extrapyramidal features, and severity of variant ataxia-telangiectasia. Ann. Neurol. 85, 170\u2013180 (2019).","journal-title":"Ann. Neurol."},{"key":"6277_CR9","unstructured":"Gatti, R. & Perlman, S. in GeneReviews (eds Adam, M. P. et al) https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK26468\/ (University of Washington, 2016)."},{"key":"6277_CR10","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1089\/hum.1996.7.17-2101","volume":"7","author":"J-Y Dong","year":"1996","unstructured":"Dong, J.-Y., Fan, P.-D. & Frizzell, R. A. Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. Hum. Gene Ther. 7, 2101\u20132112 (1996).","journal-title":"Hum. Gene Ther."},{"key":"6277_CR11","doi-asserted-by":"publisher","first-page":"4817","DOI":"10.1172\/JCI124120","volume":"129","author":"DM Ramos","year":"2019","unstructured":"Ramos, D. M. et al. Age-dependent SMN expression in disease-relevant tissue and implications for SMA treatment. J. Clin. Invest. 129, 4817\u20134831 (2019).","journal-title":"J. Clin. Invest."},{"key":"6277_CR12","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297\u20131303 (2010).","journal-title":"Genome Res."},{"key":"6277_CR13","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1101\/gr.129684.111","volume":"22","author":"DC Koboldt","year":"2012","unstructured":"Koboldt, D. C. et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22, 568\u2013576 (2012).","journal-title":"Genome Res."},{"key":"6277_CR14","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","volume":"15","author":"S Kim","year":"2018","unstructured":"Kim, S. et al. Strelka2: fast and accurate calling of germline and somatic variants. Nat. Methods 15, 591\u2013594 (2018).","journal-title":"Nat. Methods"},{"key":"6277_CR15","doi-asserted-by":"publisher","first-page":"i333","DOI":"10.1093\/bioinformatics\/bts378","volume":"28","author":"T Rausch","year":"2012","unstructured":"Rausch, T. et al. DELLY: structural variant discovery by integrated paired-end and split-read analysis. Bioinformatics 28, i333\u2013i339 (2012).","journal-title":"Bioinformatics"},{"key":"6277_CR16","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1093\/bioinformatics\/btp394","volume":"25","author":"K Ye","year":"2009","unstructured":"Ye, K., Schulz, M. H., Long, Q., Apweiler, R. & Ning, Z. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics 25, 2865\u20132871 (2009).","journal-title":"Bioinformatics"},{"key":"6277_CR17","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1101\/gr.218032.116","volume":"27","author":"EJ Gardner","year":"2017","unstructured":"Gardner, E. J. et al. The mobile element locator tool (MELT): population-scale mobile element discovery and biology. Genome Res. 27, 1916\u20131929 (2017).","journal-title":"Genome Res."},{"key":"6277_CR18","doi-asserted-by":"publisher","first-page":"3836","DOI":"10.1038\/s41467-021-24041-8","volume":"12","author":"C Chu","year":"2021","unstructured":"Chu, C. et al. Comprehensive identification of transposable element insertions using multiple sequencing technologies. Nat. Commun. 12, 3836 (2021).","journal-title":"Nat. Commun."},{"key":"6277_CR19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013424 (2015).","journal-title":"Genet. Med."},{"key":"6277_CR20","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","volume":"176","author":"K Jaganathan","year":"2019","unstructured":"Jaganathan, K. et al. Predicting splicing from primary sequence with deep learning. Cell 176, 535\u2013548 (2019).","journal-title":"Cell"},{"key":"6277_CR21","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","volume":"99","author":"NM Ioannidis","year":"2016","unstructured":"Ioannidis, N. M. et al. REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am. J. Hum. Genet. 99, 877\u2013885 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"6277_CR22","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1056\/NEJMoa2035790","volume":"385","author":"D Smedley","year":"2021","unstructured":"Smedley, D. et al. 100,000 Genomes pilot on rare-disease diagnosis in health care\u2014preliminary report. N. Engl. J. Med. 385, 1868\u20131880 (2021).","journal-title":"N. Engl. J. Med."},{"key":"6277_CR23","doi-asserted-by":"publisher","unstructured":"Martin, M. et al. WhatsHap: fast and accurate read-based phasing. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/085050 (2016).","DOI":"10.1101\/085050"},{"key":"6277_CR24","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1089\/1066527041410418","volume":"11","author":"G Yeo","year":"2004","unstructured":"Yeo, G. & Burge, C. B. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J. Comput. Biol. 11, 377\u2013394 (2004).","journal-title":"J. Comput. Biol."},{"key":"6277_CR25","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1261\/rna.066290.118","volume":"24","author":"JM Paggi","year":"2018","unstructured":"Paggi, J. M. & Bejerano, G. A sequence-based, deep learning model accurately predicts RNA splicing branchpoints. RNA 24, 1647\u20131653 (2018).","journal-title":"RNA"},{"key":"6277_CR26","first-page":"320","volume":"59","author":"CM McConville","year":"1996","unstructured":"McConville, C. M. et al. Mutations associated with variant phenotypes in ataxia-telangiectasia. Am. J. Hum. Genet. 59, 320\u2013330 (1996).","journal-title":"Am. J. Hum. Genet."},{"key":"6277_CR27","doi-asserted-by":"crossref","unstructured":"Perlman, S. L., Boder, E., Sedgewick, R. P. & Gatti, R. A. in Handbook of Clinical Neurology Vol. 103 (eds Subramony, S. H. & D\u00fcrr, A.) 307\u2013332 (Elsevier, 2012).","DOI":"10.1016\/B978-0-444-51892-7.00019-X"},{"key":"6277_CR28","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1086\/301706","volume":"62","author":"T Stankovic","year":"1998","unstructured":"Stankovic, T. et al. ATM mutations and phenotypes in ataxia-telangiectasia families in the british isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am. J. Hum. Genet. 62, 334\u2013345 (1998).","journal-title":"Am. J. Hum. Genet."},{"key":"6277_CR29","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1086\/302418","volume":"64","author":"SN Teraoka","year":"1999","unstructured":"Teraoka, S. N. et al. Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences. Am. J. Hum. Genet. 64, 1617\u20131631 (1999).","journal-title":"Am. J. Hum. Genet."},{"key":"6277_CR30","doi-asserted-by":"publisher","first-page":"6007","DOI":"10.1073\/pnas.0608616104","volume":"104","author":"L Du","year":"2007","unstructured":"Du, L., Pollard, J. M. & Gatti, R. A. Correction of prototypic ATM splicing mutations and aberrant ATM function with antisense morpholino oligonucleotides. Proc. Natl Acad. Sci. USA 104, 6007\u20136012 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"6277_CR31","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s10875-012-9846-1","volume":"33","author":"J Mallott","year":"2013","unstructured":"Mallott, J. et al. Newborn screening for SCID identifies patients with ataxia telangiectasia. J. Clin. Immunol. 33, 540\u2013549 (2013).","journal-title":"J. Clin. Immunol."},{"key":"6277_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s42764-019-00003-9","volume":"1","author":"D Menolfi","year":"2020","unstructured":"Menolfi, D. & Zha, S. ATM, DNA-PKcs and ATR: shaping development through the regulation of the DNA damage responses. Genome Instab. Dis. 1, 47\u201368 (2020).","journal-title":"Genome Instab. Dis."},{"key":"6277_CR33","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/humu.22016","volume":"33","author":"MMM Verhagen","year":"2012","unstructured":"Verhagen, M. M. M. et al. Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: a genotype-phenotype study. Hum. Mutat. 33, 561\u2013571 (2012).","journal-title":"Hum. Mutat."},{"key":"6277_CR34","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S1071-9091(98)80007-7","volume":"5","author":"TO Crawford","year":"1998","unstructured":"Crawford, T. O. Ataxia telangiectasia. Semin. Pediatr. Neurol. 5, 287\u2013294 (1998).","journal-title":"Semin. Pediatr. Neurol."},{"key":"6277_CR35","doi-asserted-by":"crossref","unstructured":"Nissenkorn, A. & Ben-Zeev, B. in Handbook of Clinical Neurology Vol. 132 (eds Islam, M. P. & Roach, S.) 199\u2013214 (Elsevier, 2015).","DOI":"10.1016\/B978-0-444-62702-5.00014-7"},{"key":"6277_CR36","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/dmcn.13052","volume":"58","author":"TJ Jackson","year":"2016","unstructured":"Jackson, T. J. et al. Longitudinal analysis of the neurological features of ataxia-telangiectasia. Dev. Med. Child Neurol. 58, 690\u2013697 (2016).","journal-title":"Dev. Med. Child Neurol."},{"key":"6277_CR37","doi-asserted-by":"publisher","first-page":"eaal5209","DOI":"10.1126\/scitranslmed.aal5209","volume":"9","author":"BB Cummings","year":"2017","unstructured":"Cummings, B. B. et al. Improving genetic diagnosis in Mendelian disease with transcriptome sequencing. Sci. Transl. Med. 9, eaal5209 (2017).","journal-title":"Sci. Transl. Med."},{"key":"6277_CR38","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.3390\/ijms20205053","volume":"20","author":"M Nassisi","year":"2019","unstructured":"Nassisi, M. et al. Prevalence of ABCA4 deep-intronic variants and related phenotype in an unsolved \u201cone-hit\u201d cohort with Stargardt disease. Int. J. Mol. Sci. 20, 5053 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"6277_CR39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ajo.2020.06.027","volume":"219","author":"M Del Pozo-Valero","year":"2020","unstructured":"Del Pozo-Valero, M. et al. Genotype\u2013phenotype correlations in a Spanish cohort of 506 families with biallelic ABCA4 pathogenic variants. Am. J. Ophthalmol. 219, 195\u2013204 (2020).","journal-title":"Am. J. Ophthalmol."},{"key":"6277_CR40","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","volume":"377","author":"RS Finkel","year":"2017","unstructured":"Finkel, R. S. et al. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N. Engl. J. Med. 377, 1723\u20131732 (2017).","journal-title":"N. Engl. J. Med."},{"key":"6277_CR41","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1056\/NEJMoa2009965","volume":"384","author":"G Baranello","year":"2021","unstructured":"Baranello, G. et al. Risdiplam in type 1 spinal muscular atrophy. N. Engl. J. Med. 384, 915\u2013923 (2021).","journal-title":"N. Engl. J. Med."},{"key":"6277_CR42","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1086\/318810","volume":"68","author":"SA Slaugenhaupt","year":"2001","unstructured":"Slaugenhaupt, S. A. et al. Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am. J. Hum. Genet. 68, 598\u2013605 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"6277_CR43","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1038\/s41467-021-24705-5","volume":"12","author":"M Ajiro","year":"2021","unstructured":"Ajiro, M. et al. Therapeutic manipulation of IKBKAP mis-splicing with a small molecule to cure familial dysautonomia. Nat. Commun. 12, 4507 (2021).","journal-title":"Nat. Commun."},{"key":"6277_CR44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/ajmg.c.32017","volume":"193","author":"J Vockley","year":"2023","unstructured":"Vockley, J. et al. Whole-genome sequencing holds the key to the success of gene-targeted therapies. Am. J. Med. Genet. 193, 19\u201329 (2023).","journal-title":"Am. J. Med. Genet."},{"key":"6277_CR45","doi-asserted-by":"crossref","unstructured":"The cost of getting personal. Nat. Med. 25, 1797 (2019).","DOI":"10.1038\/s41591-019-0700-3"},{"key":"6277_CR46","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"6277_CR47","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1158\/0008-5472.CAN-17-0337","volume":"77","author":"JT Robinson","year":"2017","unstructured":"Robinson, J. T., Thorvaldsd\u00f3ttir, H., Wenger, A. M., Zehir, A. & Mesirov, J. P. Variant review with the integrative genomics viewer. Cancer Res. 77, e31\u2013e34 (2017).","journal-title":"Cancer Res."},{"key":"6277_CR48","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1093\/bioinformatics\/btr330","volume":"27","author":"P Danecek","year":"2011","unstructured":"Danecek, P. et al. The variant call format and VCFtools. Bioinformatics 27, 2156\u20132158 (2011).","journal-title":"Bioinformatics"},{"key":"6277_CR49","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1093\/bioinformatics\/btq559","volume":"26","author":"A Manichaikul","year":"2010","unstructured":"Manichaikul, A. et al. Robust relationship inference in genome-wide association studies. Bioinformatics 26, 2867\u20132873 (2010).","journal-title":"Bioinformatics"},{"key":"6277_CR50","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren, W. et al. The Ensembl Variant Effect Predictor. Genome Biol 17, 122 (2016).","journal-title":"Genome Biol"},{"key":"6277_CR51","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434\u2013443 (2020).","journal-title":"Nature"},{"key":"6277_CR52","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41586-021-03205-y","volume":"590","author":"D Taliun","year":"2021","unstructured":"Taliun, D. et al. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program. Nature 590, 290\u2013299 (2021).","journal-title":"Nature"},{"key":"6277_CR53","doi-asserted-by":"publisher","first-page":"D936","DOI":"10.1093\/nar\/gks1213","volume":"41","author":"I Lappalainen","year":"2013","unstructured":"Lappalainen, I. et al. dbVar and DGVa: public archives for genomic structural variation. Nucleic Acids Res. 41, D936\u2013D941 (2013).","journal-title":"Nucleic Acids Res."},{"key":"6277_CR54","doi-asserted-by":"publisher","first-page":"D986","DOI":"10.1093\/nar\/gkt958","volume":"42","author":"JR MacDonald","year":"2014","unstructured":"MacDonald, J. R., Ziman, R., Yuen, R. K. C., Feuk, L. & Scherer, S. W. The Database of Genomic Variants: a curated collection of structural variation in the human genome. Nucleic Acids Res. 42, D986\u2013D992 (2014).","journal-title":"Nucleic Acids Res."},{"key":"6277_CR55","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-020-2287-8","volume":"581","author":"RL Collins","year":"2020","unstructured":"Collins, R. L. et al. A structural variation reference for medical and population genetics. Nature 581, 444\u2013451 (2020).","journal-title":"Nature"},{"key":"6277_CR56","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum, M. J. et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 46, D1062\u2013D1067 (2018).","journal-title":"Nucleic Acids Res."},{"key":"6277_CR57","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1038\/gim.2018.42","volume":"20","author":"LG Biesecker","year":"2018","unstructured":"Biesecker, L. G. & Harrison, S. M. The ACMG\/AMP reputable source criteria for the interpretation of sequence variants. Genet. Med. 20, 1687\u20131688 (2018).","journal-title":"Genet. Med."},{"key":"6277_CR58","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1002\/humu.23626","volume":"39","author":"AN Abou Tayoun","year":"2018","unstructured":"Abou Tayoun, A. N. et al. Recommendations for interpreting the loss of function PVS1 ACMG\/AMP variant criterion. Hum. Mutat. 39, 1517\u20131524 (2018).","journal-title":"Hum. Mutat."},{"key":"6277_CR59","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41436-019-0686-8","volume":"22","author":"ER Riggs","year":"2020","unstructured":"Riggs, E. R. et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet. Med. 22, 245\u2013257 (2020).","journal-title":"Genet. Med."},{"key":"6277_CR60","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/humu.24309","volume":"43","author":"S Gudmundsson","year":"2022","unstructured":"Gudmundsson, S. et al. Variant interpretation using population databases: lessons from gnomAD. Hum. Mutat. 43, 1012\u20131030 (2022).","journal-title":"Hum. Mutat."},{"key":"6277_CR61","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.gene.2008.09.021","volume":"427","author":"S Kishore","year":"2008","unstructured":"Kishore, S., Khanna, A. & Stamm, S. Rapid generation of splicing reporters with pSpliceExpress. Gene 427, 104\u2013110 (2008).","journal-title":"Gene"},{"key":"6277_CR62","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.cell.2015.09.054","volume":"163","author":"AB Rosenberg","year":"2015","unstructured":"Rosenberg, A. B., Patwardhan, R. P., Shendure, J. & Seelig, G. Learning the sequence determinants of alternative splicing from millions of random sequences. Cell 163, 698\u2013711 (2015).","journal-title":"Cell"},{"key":"6277_CR63","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"6277_CR64","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-06277-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-06277-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-06277-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T18:23:39Z","timestamp":1702751019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-06277-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,12]]},"references-count":64,"journal-issue":{"issue":"7971","published-print":{"date-parts":[[2023,7,27]]}},"alternative-id":["6277"],"URL":"https:\/\/doi.org\/10.1038\/s41586-023-06277-0","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,12]]},"assertion":[{"value":"22 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.K. and T.W.Y. are listed as inventors on pending patent claims (US 62\/912,997) filed by Boston Children\u2019s Hospital covering <i>ATM<\/i> splice-switching ASOs described in this study. T.W.Y. received research funding from ATCP and EveryOne Medicines, has served as a scientific consultant to Biomarin, GeneTx, Alnylam and Servier Pharmaceuticals and is a volunteer scientific advisor to several nonprofit rare disease foundations. B.M. is a co-founder, chairman and volunteer president of ATCP. J.K.T. is an employee of ATCP. A.A.P. is a Venture Partner at GV, a corporate venture group within Alphabet that invests in a number of rare disease drug development organizations, including EveryOne Medicines. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}